A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
This is an initial proof of concept, phase to study to assess the safety and efficacy
 tofimilast for the chronic maintenance treatment of adults with persistent asthma
Inclusion Criteria:

 -  Mild to moderate persistent asthma (NAEPP/GINA Step 2-3)

 -  Reversibility to albuterol at least 12% and 200 mL

 Exclusion Criteria:

 -  Any significant co-morbid disease, particularly cardiovascular

 -  Use of any maintenance therapy except short acting bronchodilators

 -  Smoking history > or = 10 years